Recently, YKL-40 was reported to be highly expressed in several types of cancers, including ovarian cancer [15], breast cancer [16], lung cancer [17], hepatocellular carcinoma [18], and glioblastoma [19]. This evidence concerns the gene CHI3L1 and cancer.